On this page
Mesalamine
Active ingredient 12 prescription 17 with labelling
Overview
Source: NDC DirectoryIngredient name
MESALAMINE
Base moiety
MESALAMINE
RxNorm CUI
UNII
4Q81I59GXC
Medication products
16
Brand names
7
Dosage forms
8
FAERS reports
55,833 · not a risk measure
- APRISO mesalamine · Capsule, Extended Release
- Canasa Mesalamine · Suppository
- Lialda mesalamine · Tablet, Delayed Release
- Mesalamine Powder
- MESALAMINE Mesalamine · Capsule
- Mesalamine High Density Powder
- Mesalamine Rectal Mesalamine · Suppository
- Mesalazine Powder
- Rowasa mesalamine · Suspension
- Mesalamine Suppository
- Mesalamine Tablet, Delayed Release
- Mesalamine Enema
- Mesalamine Capsule, Extended Release
- Mesalamine Suspension
- Mesalamine Capsule, Delayed Release
- Pentasa mesalamine · Capsule
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Suppository | 3 | Canasa, Mesalamine Rectal, Mesalamine |
| Powder | 3 | Mesalamine, Mesalamine High Density, Mesalazine |
| CAPSULE, Extended Release | 2 | APRISO, Mesalamine |
| TABLET, Delayed Release | 2 | Lialda, Mesalamine |
| Capsule | 2 | MESALAMINE, Pentasa |
| Suspension | 2 | Rowasa, Mesalamine |
| Enema | 1 | Mesalamine |
| CAPSULE, Delayed Release | 1 | Mesalamine |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |